Enanta Pharmaceuticals Statistics
NASDAQ: ENTAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
12.37+0.20 (+1.64%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 12.37 0.00%
Enanta Pharmaceuticals by the numbers
Enanta Pharmaceuticals has a market capitalization of $360.3 million based on 29.13M shares outstanding. With trailing EPS of $-2.42, Enanta Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.5% below its 50-day average and 8.2% below its 200-day average.
Average daily trading volume is 226.69K shares, or about $2.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ENTA valuation vs. peer median
| Metric | ENTA | Peer median | Difference |
|---|---|---|---|
| Market cap | $360.28M | $362.66M | -1% |
| Avg. volume | 226.69K | 1.05M | -78% |
Peer median across 8 companies: RLMD, EBS, ARCT, GALT, IRD, TTRX, CYPH, BNTC.
Valuation
- Market cap
- $360.28M
- EPS (TTM)
- $-2.42
- Shares outstanding
- 29.13M
Price and trading
- Previous close
- 12.17
- Open
- 12.09
- Day range
- 12.08 – 12.57
- 52-week range
- 10.20 – 17.15
- 52-week change
- +11.64%
- Beta
- —
- Volume
- 191.66K
- Average volume
- 226.69K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 16, 2026
Additional statistics
- Market Cap
- 360.28M
- Forward Pe
- -5.21
- Eps
- -2.42
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 17.15
- Week52 Low
- 10.20
- Avg Volume
- 226.69K
- Shares Outstanding
- 29.13M
- Ma50
- 13.09
- Ma200
- 13.47
- Earnings Date
- Nov 16, 2026
- Pct From52w High
- -27.87%
- Pct From52w Low
- 21.27%